Market Analysis and Insights: Global Plasma Fractionation Market

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.

Due to the COVID-19 pandemic, the global Plasma Fractionation market size is estimated to be worth US$ 28100 million in 2022 and is forecast to a readjusted size of US$ 47210 million by 2029 with a CAGR of 7.6% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Albumin accounting for % of the Plasma Fractionation global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Immunology segment is altered to an % CAGR throughout this forecast period.

Global Plasma Fractionation key players include Takeda, CSL, Grifols, Octapharma, Kedrion, etc. Global top five manufacturers hold a share about 75%.

North America is the largest market, with a share over 40%, followed by Europe and China, both have a share about 40 percent.

In terms of product, Immune Globulin is the largest segment, with a share about 50%. And in terms of application, the largest application is Immunology, followed by Hematology.

Global Plasma Fractionation Scope and Market Size

The global Plasma Fractionation market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Plasma Fractionation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.


Segment by Type


Albumin

Immune Globulin

Coagulation Factor

Others


Segment by Application


Immunology

Hematology

Others

By Region

United States

Europe

China

Japan

Southeast Asia

India

Other Regions


By Company


Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio